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Abstract
Reports of limited clinical significance of attenuated psychotic symptoms before age 15/16 indicate an important role of 
neurodevelopment in the early detection of psychoses. Therefore, we examined if age also exerts an influence on the preva-
lence and clinical significance of the 14 cognitive and perceptive basic symptoms (BS) used in psychosis-risk criteria and 
conceptualized as the most direct self-experienced expression of neurobiological aberrations. A random representative general 
population sample of the Swiss canton Bern (N = 689, age 8–40 years, 06/2011–05/2014) was interviewed for BS, psycho-
social functioning, and current mental disorder. BS were reported by 18% of participants, mainly cognitive BS (15%). In 
regression analyses, age affected perceptive and cognitive BS differently, indicating an age threshold for perceptive BS in late 
adolescence (around age 18) and for cognitive BS in young adulthood (early twenties)—with higher prevalence, but a lesser 
association with functional deficits and the presence of mental disorder in the below-threshold groups. Thereby, interaction 
effects between age and BS on functioning and mental disorder were commonly stronger than individual effects of age and 
BS. Indicating support of the proposed “substrate-closeness” of BS, differential age effects of perceptual and cognitive BS 
seem to follow normal brain maturation processes, in which they might occur as infrequent and temporary non-pathological 
disturbances. Their persistence or occurrence after conclusion of main brain maturation processes, however, might signify 
aberrant maturation or neurodegenerative processes. Thus, BS might provide important insight into the pathogenesis of 
psychosis and into differential neuroprotective or anti-inflammatory targets.
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Introduction
Psychoses, in particular the schizophrenia spectrum, are 
considered a fundamentally neurodevelopmental disorder 
involving two critical time windows—early (perinatal) 
brain development and adolescence—that together pro-
duce the symptomatic manifestations of the disorder [1]. 
Thus, following the increasing involvement of younger age 
groups in the early detection of psychotic disorders [2–5], 
concerns have been voiced about the likely impact of age, 
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i.e., developmental aspects, on the prevalence, clinical sig-
nificance, and psychosis-predictive value of risk criteria and 
symptoms [6]. These have been corroborated by a recent 
meta-analysis of conversion-to-psychosis rates that reported 
significantly lower rates in ultra-high-risk (UHR) samples 
comprising exclusively children and adolescents compared 
to adult or mixed adult-adolescent samples [5].
Studies of age effects on attenuated 
psychotic symptoms
The attenuated psychotic symptom (APS) criterion is the 
main UHR criterion [4, 5]. For the APS criterion as well 
as for APS themselves, an effect of age on the prevalence 
and clinical significance was recently reported from clinical 
and community studies [7–10] with the exception of one 
study of patients with 22q11 deletion syndrome [11]. These 
studies, including one on the same sample as the present 
one [8], indicate that APS, in particular perception-related 
APS, are more prevalent in samples below age 15/16, while 
at the same time they have less clinical significance in terms 
of a weaker association with functional impairments and/or 
mental disorder, incl. subsequent development of psychosis, 
below this age threshold [7–10]. The only negative study 
on 22q11 deletion syndrome patients [11] was explained by 
the high genetic liability to develop schizotypal personality 
features and psychosis, respectively, and, consequently, the 
lesser involvement of other age-related factors, e.g., develop-
ment of cognitive abilities, on the occurrence of APS [11].
The concept of basic symptoms 
and age‑related considerations
With regard to the basic symptom (BS) risk approach [12, 
13], age effects have so far been examined and described 
only with regard to their dimensional structure [14, 15]. 
BS are subtle, subjectively experienced subclinical distur-
bances in drive, affect, thinking, speech, (body) percep-
tion, motor action, central-vegetative functions, and stress 
tolerance and can usually be assessed from age 8 onwards 
[15]. They were conceptualized as the earliest subjectively 
experienced symptoms of psychosis and the most immediate 
symptomatic expression of the neurobiological correlates of 
the illness [12, 13, 16, 17]. Preliminary evidence for neuro-
biological mechanisms underlying BS indicates that diverse 
anatomical, pharmacological and functional correlates may 
be involved in the manifestation of BS in psychotic and risk 
individuals [16]. For this proposed characteristic of BS as 
being “substrate-close” [12, p. 646], it must be assumed that 
BS are influenced by neurodevelopment to an even greater 
degree than are APS.
By definition, BS differ from what patients consider to be 
their “normal” mental self, and thus, are distinct from trait-
like schizotypy features considered as part of the normal 
self. Furthermore, BS remain predominately private and are 
rarely perceivable by others, although patients’ self-initi-
ated coping strategies (including avoidance strategies and 
social withdrawal) in response to their BS may be observ-
able, e.g., as negative symptoms [13]. Due to their sponta-
neous, immediate recognition by patients as disturbances 
of their own (mental) processes, BS are also distinct from 
APS or frank psychotic symptoms, in which reality testing 
is already disturbed. Within the BS concept, (attenuated) 
psychotic symptoms are considered to arise from BS when 
everyday situations and demands overstrain patients’ already 
pathologically vulnerable information processing capac-
ity [13]. Thus, given salutary environmental and personal 
conditions (e.g., a supportive social network; good social, 
problem solving, and coping skills; or high self-efficacy), 
BS can be counterbalanced as long as their number and/or 
severity do not overextend protective factors and patients’ 
resilience [13].
While most BS may occur in other disorders, especially 
non-psychotic affective disorders [14, 15], a subset of 14 
cognitive and perceptive BS appear to be specific to psycho-
sis. These are included in the two psychosis-risk criteria [2, 
5, 14, 18]: cognitive disturbances (COGDIS) and cognitive-
perceptive BS (COPER) (Online Resource 1).
Aims and hypotheses
Following the main method employed to study age effects 
in APS [8, 9, 11], i.e., comparing predefined age groups, 
and interactions of symptoms and age by regression analy-
ses, the current study examined potential age effects in the 
prevalence and clinical significance of the 14 BS included 
in COPER and COGDIS in the general population. With 
respect to the age threshold around the age of 15/16 
described for APS, we expected an earlier or similar age 
threshold for BS, with a higher prevalence of perceptive BS 
and a lesser clinical significance in terms of a weaker asso-
ciation with impaired functioning and presence of mental 
disorders of cognitive BS in children and young adolescents 
compared to older adolescents and adults.
Materials and methods
Sample
The sample consisted of community participants in two 
studies approved by the ethics committee of the University 
of Bern: the Binational Evaluation of At-Risk Symptoms 
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in Children and Adolescents (BEARS-Kid) study [8] and 
the Bern Epidemiology At-Risk (BEAR) study [8, 19]. In 
both studies, first contact was established by an information 
letter on respective study aims, voluntariness of participa-
tion, and anonymous use of data in group statistics. For the 
BEAR study, participation in the telephone interview was 
then equated with provision of informed consent; for the 
BEARS-Kid study, written informed assent/consent was 
secured from participants and their parents.
Stratified sampling by gender (1:1) was used to randomly 
select potential participants aged 8–17 years in the BEARS-
Kid study and 16–40 years in the BEAR study from 384,000 
persons in these age groups included in the obligatory popu-
lation register of Canton Bern, Switzerland. In both studies, 
eligibility criteria included appropriate age, main residence 
in Canton Bern, and an available telephone number. Inter-
views were discontinued if participants had a lifetime diag-
nosis of psychosis or insufficient German, French, or English 
language skills. Recruitment and telephone assessments for 
the BEAR study were conducted over 14 months; recruit-
ment and face-to-face assessments for the BEARS-Kid 
study over 33 months. Prior to merging data, a feasibility 
study examining the correspondence of telephone and face-
to-face assessments of BS reported excellent concordance 
rates (78–100%) between these two assessment modes [20], 
thus indicating that data of both studies could be merged 
and compared without danger of introducing a systematic 
assessment bias.
The participation rate of those eligible was 41.5% in the 
BEARS-Kid study and 66.4% in the BEAR study. In both 
studies, participants and non-participants did not differ in 
age, gender, or nationality. Main reasons for refusal were 
lack of interest in the topic (BEARS-Kid: 49.6%; BEAR: 
52.9%) or lack of time (BEARS-Kid: 33.8%; BEAR: 44.5%).
Where allowed by the subsample size, each child/ado-
lescent (aged 8–17 years) was randomly matched by gender 
and highest parental educational level to one participant of 
each of the four adult age groups (18–19, 20–24, 25–29, 
and 30–40 years). Our final sample (N = 689) comprised 535 
adults and 154 children/adolescents.
Measures
The Schizophrenia Proneness Instrument, Adult (SPI-
A; [21]; in BEAR study) and Child and Youth versions 
(SPI-CY; [22]; in BEARS-Kid study) were used to assess 
BS and additional risk criteria requirements for novelty 
and frequency (Online Resource 1). The definitions of 
corresponding BS as well as of BS criteria are equal in 
both versions of the SPI. More specifically, both criteria 
require that the respective BS occurred at least once per 
week within the past 3 months (frequency requirement) 
and had a distinct first occurrence (novelty requirement). 
As in APS [8–10], for the current analysis, perceptive and 
cognitive BS were distinguished rather than employ the 
partially overlapping criteria for BS (Online Resource 
1). Perceptive BS included at least one visual or acous-
tic perception disturbance; cognitive BS included thought 
interference, blockages, pressure, and perseveration; dis-
turbances of receptive and expressive speech, of abstract 
thinking, or of discriminating between ideas and percep-
tions; captivation of attention by details of the visual field; 
inability to divide attention; unstable ideas of reference; 
and derealization. Because the SPI-CY requires a mini-
mum age of 13 years for the assessment of three of the 14 
BS included in COPER and COGDIS (Online Resource 
1), main analyses were conducted on the 11 BS assessed 
across all age groups to avoid a negative selection bias in 
the youngest age group.
Furthermore, the positive items of the Structured Inter-
view for Psychosis-Risk Syndromes (SIPS) [23] were 
assessed; and participants (or a parent, in those of age 8–15) 
were asked about first or second degree family members 
with mental problems, treated or untreated, and the diag-
nosis or, if unknown or never seeking help, a description of 
these problems (and treatment, if applicable).
Symptom-independent current global level of psychoso-
cial functioning was estimated using the Social and Occu-
pational Functioning Assessment Scale (SOFAS); a score 
≤ 70 was considered indicative of low, i.e., clinically sig-
nificant, impairment in functioning. The Mini-International 
Neuropsychiatric Interview [24] and its children’s version 
[25] were used to assess current mental disorders according 
to DSM-IV criteria.
In both the BEAR and the BEARS-Kid study, interview-
ers (all clinical psychologists) received intensive 3-month 
training, especially in the semi-structured context-depend-
ent personalized assessment of psychosis-risk symptoms 
and mental disorders, to achieve a ≥ 95% concordance rate 
with the trainers (F.S.-L. and C.M.) before the conduction of 
interviews. In line with clinical assessments, this routinely 
included gathering thorough information on:
• novelty/first recognition of the respective disturbance
• situations in which the phenomenon had occurred,
• the degree of externalization/conviction (in case of APS),
• participant’s reaction in response to/explanation of the 
potential symptom incl. distress (self-perception as a dis-
turbance in own mental processes as an obligate criterion 
for the rating of BS),
• reactions of others (in case of APS; in particular, others’ 
opinion on potential “unusual thought content” to control 
for ‘normal’ subcultural believes),
• potential associations with substance use, somatic/known 
neurological conditions or hypnagogic/hypnopompic 
states.
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Additionally, weekly supervisions of all symptom ratings 
performed by FSL or CM ensured excellent, reliable data 
quality prior to data entry.
Statistical analysis
Using SPSS 21.0., frequencies were compared by Chi square 
test, and non-normally distributed interval and ordinal data 
were evaluated by Mann–Whitney test. In accordance 
with other studies of age effects in APS [8, 9, 11], logistic 
regression analyses were used to calculate (I) effects of age 
groups (8–12; 13–15; 16–17; 18–19; 20–24; 25–29; 30–40) 
on prevalence rates of BS and their novelty and frequency 
requirements, and (II) effects of age, BS and BS criteria 
requirements, and their interaction with age on low psycho-
social functioning, and the presence of at least one axis-
I disorder as dependent variables. To test (I), we used the 
enter method and, again in accordance with previous stud-
ies [8, 9], the age group with a peak onset of first-episode 
psychosis (20–24 years) as a reference group. Additionally, 
bootstrapping was performed to test the reliability of results. 
To test (II), we employed stepwise logistic regression analy-
ses using both the backward and the forward selection to 
control for the different suppressor effects associated with 
each selection mode and, thus, ensure stability of results. 
In each analysis, the respective BS, age and the “BS × age” 
interaction term entered as predictors to test the interaction 
effect against the simple effects. Age rather than age group 
was entered in these analyses because of the expected small 
numbers of low functioning and mental disorders per age 
group. A “BS × age” interaction was only considered as rel-
evant and inspected for its direction by interaction graphs 
when selected as a significant predictor in both the forward 
and backward selection. Since bootstrapping cannot be per-
formed with the stepwise regression analysis in SPSS, we 
subsequently tested the reliability of relevant “BS × age” 
interactions using bootstrapping of the enter method in 
regression analysis. Throughout, goodness-of-fit was esti-
mated by the Omnibus test.
For the final sensitivity analyses, stepwise regression 
analyses were repeated separately for age groups below and 
above the suggested age thresholds to test if these thresh-
olds could fully account for age effects, in which case age 
effects should be missing within the age subsamples above 
and below the age threshold, respectively.
Results
Prevalence of BS and age
At least one of the 14 BS and at least one of the 11 BS 
assessed in all age groups were reported by 125 participants 
(18.1%) and 105 participants (15.2%), respectively, within 
the 3 months prior to the interview (Fig. 1). Report of at 
least one BS was unrelated to gender, nationality, parental 
education, family history of psychosis, and low functioning, 
but was related to age and other psychopathology, i.e., pres-
ence of axis-I disorder or APS (Table 1). COPER criteria 
were met by 23 participants (3.3%); of these, eight (1.2%) 
also met the COGDIS criteria.
Using 20- to 24-year-olds as the reference group, logistic 
regression analyses indicated a pattern of differential age 
thresholds for cognitive and perceptive BS. Perceptive BS, 
especially when occurring at least once in a week (= fre-
quency requirement), were more frequent below age 18. 
Cognitive BS and COGDIS decreased in the early twenties 
(Table 2 and Online Resource 2). Omnibus tests revealed 
acceptable goodness-of-fit for 12 of 15 models; only the 
three models using presence and novelty requirements of 
perceptive BS and the frequency requirement of at least 
one of the 11 BS assessed across all age groups remained 
insignificant. Although models for the infrequent COPER 
and COGDIS also possessed sufficient goodness-of-fit, age 
groups remained largely insignificant (Table 3).
Clinical significance of BS and age
Logistic regressions with low functioning as the dependent 
variable indicated that the interactions of the 11 BS assessed 
across all age groups with age, rather than the BS parameters 
themselves, predicted low functioning (Table 4). All selected 
interaction terms also became significant in univariate logis-
tic regression after bootstrapping. Visual inspection of the 
interaction graphs (Online Resource 3) showed that, in the 
presence of the respective BS parameter, low functioning 
always became more likely with advancing age.
Fig. 1  Prevalence rates of basic symptoms (BS) in the whole sample 
(N = 689)
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Logistic regressions with at least one axis-I disorder 
as the dependent variable, however, indicated that all BS 
parameters except the simple report of at least one of the 
nine cognitive BS assessed across all ages were signifi-
cant predictors of a current non-psychotic mental disorder 
(Table 5). The interaction of BS with age became significant 
mostly when the novelty requirement was met, i.e., when BS 
were reported as having occurred at some time in the past as 
a previously unknown or considerably less frequent distur-
bance (Table 5). All selected interaction terms also became 
significant in univariate logistic regression after bootstrap-
ping. Again, interaction graphs (Online Resource 4) indi-
cated that, in the presence of the respective BS parameter, 
mental disorders became more likely with advancing age.
Examination of age thresholds
Finally, sensitivity analyses were run on the suggested 
age thresholds for cognitive and perceptive BS (Online 
Resources 5 and 6) to examine if an age effect was still 
detectable within the respective age subgroups. Because 
the age threshold for cognitive BS ran through the refer-
ence group of 20- to 24-year-olds, we tested both “borders”, 
i.e., age 20 and age 25, to examine a bias towards either 
age. First, using a 20-year threshold in the nine cognitive 
BS assessed across all age groups, within the younger age 
group, only the interaction of age with cognitive BS meeting 
the frequency requirement of occurrence at least once in a 
week predicted low functioning and the presence of mental 
disorder—in the latter case, only in the older age group. 
Within the older age subgroup, a “cognitive BS × age” effect 
on low functioning was revealed. Additionally, when all 12 
cognitive BS were considered, interaction effects of the 12 
cognitive BS meeting the novelty requirements on axis-I 
disorders and of the presence of the 12 cognitive BS on low 
functioning became significant in the older age group. These 
findings did not change when using a 25-year threshold, 
thus indicating an age threshold for cognitive BS “within 
the early twenties”.
With regard to the 18-year threshold in perceptive BS, only 
one within-group age interaction effect with age on low func-
tioning was detected in the older age group, while age effects 
Table 2  Prevalence and effects of age on the report of the 11 criteria-relevant basic symptoms (BS) assessed in all age groups, irrespective of 
novelty and frequency requirements; binary logistic regression analyses with method “enter” and 20- to 24-year-olds as the reference age group
Significant predictors (p < 0.05) are in bold type, predictors with significance at statistical trend (p < 0.10) in bold italics
a Lower prevalence in comparison to 20- to 24-year-olds became significant when the cognitive BS that are only assessable from age 13 onwards 
were considered (Exp (β) = 0.473; 95% CI 0.23–0.98, p (bootstrap) = 0.040)
b Higher prevalence in comparison to 20- to 24-year-olds reached statistical trend level when the cognitive BS that are only assessable from age 
13 onwards were considered (Exp (β) = 1.847; 95% CI 0.89–3.83, p (bootstrap) = 0.083)
Age group (years) β SE Wald (df = 1) p after bootstrap Exp (β) 95% CI Number 
present
% present
≥ 1 BS (in 20–24 years: n = 18, 12%)
 8–12 1.018 0.420 5.872 0.021 2.768 1.22–6.31 12 27
 13–15 1.432 0.451 10.061 0.001 4.186 1.73–10.14 11 36
 16–17 0.595 0.381 2.431 0.113 1.812 0.86–3.83 15 19
 18–19 0.980 0.357 7.551 0.006 2.664 1.32–5.36 21 26
 25–29a − 0.566 0.413 1.879 0.156 0.568 0.25–1.28 10 7
 30–40 0.000 0.355 0.000 0.999 1.000 0.50–2.00 18 12
≥ 1 cognitive BS (in 20–24 years: n = 12, 8%)
 8–12 0.946 0.492 3.696 0.049 2.577 0.98–6.76 8 18
 13–15 1.584 0.497 10.164 0.002 4.875 1.84–12.91 9 29
 16–17b 0.671 0.443 2.296 0.116 1.956 0.82–4.66 11 14
 18–19 1.225 0.402 9.280 0.001 3.405 1.55–7.49 18 22
 25–29 − 0.496 0.490 1.024 0.299 0.233 0.23–1.59 7 5
 30–40 0.000 0.425 0.000 1.000 0.435 0.44–2.30 12 8
≥ 1 perceptive BS (in 20–24 years: n = 7, 5%)
 8–12 0.972 0.612 2.521 0.094 2.643 0.80–8.77 5 11
 13–15 0.818 0.720 1.289 0.255 2.265 0.55–9.29 3 10
 16–17 0.882 0.537 2.694 0.088 2.416 0.84–6.93 8 10
 18–19 0.094 0.642 0.021 0.8674 1.098 0.31–3.87 4 5
 25–29 − 0.504 0.638 0.625 0.431 0.604 0.17–2.11 4 3
 30–40 − 0.161 0.568 0.080 0.765 0.851 0.28–2.59 6 4
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on mental disorder remained only for the novelty requirement 
in 18- to 40-year-olds. Within 8- to 17-year-olds, all three 
interactions with age maintained their significant effect on the 
presence of a mental disorder, when age entered the model 
as a second significant predictor. These results indicated that 
the association between perceptive BS and an axis-I disorder 
became stronger with advancing age, in particular when per-
ceptive BS were not reported as a trait (i.e., met the novelty 
requirement) and occurred at least once in a week (i.e., met the 
frequency requirement).
Overall, the majority of interaction effects that had been 
significant in the whole sample were not significant any 
longer after splitting the sample according to the respective 
age thresholds suggested for cognitive and perceptive BS. 
Commonly, interactions terms became significant within an 
age subgroup when the frequency requirement or at least the 
novelty requirement was met, indicating that the age effect 
on the association of the sheer prevalence of BS with mental 
disorder or impaired functioning was predominately related to 
the respective age threshold. However, in all instances in which 
interaction terms became significant, they indicated that, in 
the presence of the respective BS parameter, low functioning 
and mental disorder, respectively, became more likely with 
advancing age.
Discussion
Prevalence and clinical significance of BS
Within our random, representative community sample of 
never-psychotic 8- to 40-year-olds, 18.1% reported BS 
included in either COPER or COGDIS, mainly cogni-
tive BS, in clinical interviews carried out by well-trained 
clinical psychologists. Only 3.3% met BS criteria, in all 
cases COPER; 1.2% additionally met criteria for COG-
DIS, which is part of the clinical high-risk criteria rec-
ommended for early detection of psychosis within the 
guidance project of the European Psychiatric Association 
[5]. Thus, at least one of the 14 BS included in COPER 
and COGDIS was reported almost twice as frequently as 
were APS (9.9%), and COPER was reported about 2.5 
times more often than was the APS criterion (1.3%) in 
the same sample [8]. In contrast, COGDIS was as rare as 
the APS criterion, and at 4.4%, at least one perceptive BS 
Table 3  Effect of age on presence of basic symptom (BS) criteria
Binary logistic regression analysis with method “enter” and 20- to 24-year-olds as the reference age group
Significant predictors (p < 0.05) are in bold type, predictors with significance at statistical trend (p < 0.10) in bold italics
N (%) in reference group of 20- to 24-year-olds: COPER: n = 6, 4%; COGDIS: n = 2, 1%
a Both BS criteria include two cognitive BS (thought blockages and derealisation included in COPER; and thought blockages and disturbances 
of abstract thinking included in COGDIS) that are only assessable from age 13 onwards, thus biasing both BS criteria towards lower frequencies 
and, consequently, non-significant results in the 8- to 12-year-olds
Age group (years) β SE Wald (df = 1) p after bootstrap Exp (β) 95% CI N present % present
Cognitive-perceptive BS (COPER)
 8–12a − 17.991 5991.614 0 0.001 0 n = 0 0
 13–15 0.979 0.736 1.765 0.137 2.661 0.63–11.27 3 10
 16–17 0.294 0.661 0.198 0.646 1.342 0.37–4.90 4 5
 18–19 0.491 0.622 0.623 0.432 1.634 0.48–5.53 5 6
 25–29 − 1.751 1.086 2.596 0.065 0.174 0.02–1.46 1 1
 30–40 − 0.419 0.656 0.408 0.503 0.658 0.18–2.38 4 3
Cognitive disturbances (COGDIS)
 8–12a − 16.866 5991.614 0 0.001 0 n = 0 0
 13–15 1.663 1.020 2.657 0.010 5.276 0.71–38.97 2 7
 16–17 − 16.866 4550.958 0 0.001 0 n = 0 0
 18–19 1.079 0.923 1.366 0.106 2.942 0.48–17.98 3 4
 25–29 − 16.866 3349.414 0 0.001 0 n = 0 0
 30–40 − 0.700 1.230 0.324 0.249 0.497 0.05–5.54 1 1
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occurred as infrequently as did at least one perceptive APS 
(4.9%) [8]. Report of BS was moderately related to report 
of APS and, though to a lesser degree, to more frequent 
current non-psychotic DSM-IV axis-I disorders. Further-
more, when reported to occur not as a trait (= novelty 
requirement) and/or at least weekly (= frequency require-
ment), BS were related to functional impairment. Thus, as 
reported for APS [8], our findings indicate some clinical 
significance of BS at the community level with a stronger 
relation to subthreshold psychotic symptomatology than 
to non-psychotic disorders.
Effects of age on prevalence and clinical significance 
of BS
As expected from recent reports on APS [7–9], age effects 
were also revealed in prevalence and clinical significance of 
BS. Yet, unexpectedly, these did not follow the age thresh-
old in the psychopathological significance of APS around 
age 15/16 years [7–10]. Compared to APS assessed in the 
same sample [8], developmental aspects indicated by age 
seemed to play an even stronger role in BS. APS in the com-
munity had shown more direct associations with functional 
impairment and the presence of a mental disorder and lesser 
interactions with age [8]. This stronger impact of age, i.e., 
neurodevelopmental state, on BS is well in line with the 
proposed strong neurobiological basis of BS [12, 13, 16]. 
All interactions of BS and age pointed toward an increase 
in clinical significance (i.e., an increase in their association 
with the presence of either a mental disorder or functional 
impairment) with age, while the prevalence rates of BS, both 
cognitive and perceptive, decreased with age.
With regard to prevalence rates, the infrequency of 
events, especially in terms of perceptive BS, and the rather 
small subsample size of some age groups likely constrained 
the power of age group analyses, despite our large sample. 
Yet, even with this limitation, regression analyses revealed 
an age-related pattern in BS prevalence that differed between 
perceptive and cognitive BS. These prevalence patterns sug-
gested an age threshold for perceptive BS around the turn 
from late adolescence to young adulthood (i.e., age 18) and 
one for cognitive BS in young adulthood (i.e., within the 
early twenties) rather than a general effect of age across 
all age groups. In particular when BS were reported as 
occurring infrequently (i.e., did not meet the frequency 
requirement) but also when they were reported as a trait-
like phenomenon (i.e., did not meet the novelty require-
ment), age effects on the association between BS and either 
proxy measure of clinical significance (i.e., mental disorder 
and functional impairment) could only rarely be observed 
within the age subgroups below and above the respective age 
threshold. Further, the clinical significance of both cognitive 
and perceptive BS was lower in the age subgroups below 
their respective threshold compared to the subgroup above 
the respective age threshold.
While differences between perceptive and cognitive BS 
were expected, the emerging age thresholds above the age 
threshold for APS were unexpected. The BS concept and 
current models of symptom development in the early phases 
of psychosis consistently assume that (attenuated) psychotic 
symptoms follow BS [4, 5, 12, 13]; and first retrospective 
assessments of prodromal symptoms in patients with first-
episode psychosis have broadly supported this view [14]. 
Consequently, from this assumed earlier onset of BS, we 
had expected a younger, if different, age threshold compared 
to the APS threshold of 15/16 years [7–9, 11]. Our results, 
however, indicate that an earlier onset in the early course of 
psychosis does not translate into an earlier age threshold in 
prevalence and clinical significance.
An integrated developmental model 
of psychosis‑risk symptoms
A possible explanation of these diverging age thresholds 
for APS and BS is offered by the BS concept. This assumes 
BS to be “substrate-close” [12], i.e., to be the most direct 
expression of the underlying neurobiological aberrations, 
and APS and psychotic symptoms to be the result of dys-
functional coping with daily hassles and adversities [13]. In 
light of this, APS would be affected primarily by the devel-
opment of cognitive abilities, while BS would be affected 
primarily by brain maturation (Fig. 2).
Brain maturation progresses from bottom to top, central 
to peripheral, and back to front within the first 2.5 decades 
of life [26, 27] and, thus, continues into young adulthood, 
particularly in the frontal regions. Consequently, following 
the above line of argument, BS-like phenomena likely occur 
temporarily, infrequently (i.e., below the requirements on 
frequencies by BS criteria), and randomly as part of major 
brain maturation processes without being clinically signifi-
cant and decrease in prevalence once brain maturation has 
attained the adult corridor. This interpretation fits well with 
the age threshold of 18 years for perceptive BS, which are 
likely related to earlier maturing occipitotemporal regions, 
and an age threshold within the early twenties for cognitive 
BS, which are likely related to the lastly maturing frontal 
regions [28, 29] (Fig. 2).
On a cellular level, prefrontal inhibitory synapses strongly 
increase from age 15 onwards and reach their maximum in 
the early twenties, while excitatory synapses are eliminated 
[30, 31]. Thus, as supported by first electrophysiological 
and imaging studies on COPER/COGDIS samples or using 
SPI-A total scores, BS might be an expression of an altered 
excitatory–inhibitory balance [16].
In contrast, APS might be more prevalent but less clini-
cally significant before the development of major cognitive 
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abilities [32]. The BS concept [13, 33] and developmental 
models of APS [34, 35] assume that (attenuated) psychotic 
symptoms result from dysfunctional coping with first symp-
toms, e.g., BS and/or stressors, when a vulnerable person’s 
resilience and protective factors are overstrained (Fig. 2). 
These dysfunctional coping strategies might include the 
development of inadequate explanatory models [34]. Thus, 
dysfunctional coping might be the link between APS and 
functional impairment, which were found to be moderately 
related, while BS were only related to functional impairment 
in the rare event of their at-least-weekly occurrence (Fig. 2).
As a result of the above and in line with a neurodevelop-
mental model of psychosis [1, 36], the cognitive and percep-
tive BS included in COPER and COGDIS might signal a 
risk of developing a psychosis that is potentially related to 
aberrant brain maturation, e.g., by excessive synaptic prun-
ing [16, 37, 38], when these BS begin in adolescence, occur 
frequently and persist beyond the respective brain matura-
tion age. In contrast, they might signal psychosis-risk related 
to neurodegenerative mechanisms, such as neuroinflamma-
tion or oxidative stress [39, 40], when they start or re-emerge 
after brain maturation is complete (Fig. 2). Should this view 
be supported in future, it will not only give important new 
insight into the pathogenesis of psychosis, but will also 
have important therapeutic implications. It would support 
the search for both neuroprotective and anti-inflammatory 
interventions for BS—depending on their course, and the 
emphasis on cognitive–behavioral interventions for APS. 
The combination of both interventions [41], however, might 
be indicated in patients for whom the highest risk for psy-
chosis has already been demonstrated, i.e., help-seekers with 
both APS and COGDIS [42].
Fig. 2  Illustration of the possible relationship between basic symp-
toms and brain maturation, and between attenuated psychotic symp-
toms and maturation of cognitive abilities. This model assumes that 
A subtle subclinical disturbances in cognitive and perceptive infor-
mation processing phenomenologically identical to basic symptoms 
(BS) might occur during childhood and adolescence as infrequent 
temporary expressions of minor transient dysfunctions in the wake 
of brain maturation processes (gray-shaded curve). However, if these 
disturbances, i.e., BS, occur more frequently (i.e., meet the frequency 
requirements of the BS criteria) and are persistent (dotted line) they 
might indicate disturbances in brain maturation that, in line with a 
neurodevelopmental model of psychosis, predispose to the develop-
ment of psychosis. A genetic predisposition, childhood adversities or 
other risk factors as well as stressful life-events and cognitions pro-
moting the development of attenuated psychotic symptoms (APS), 
such as poor coping, externalization biases or poor source monitor-
ing, (risk factors/stressors indicated by flashes) might further fuel the 
development and persistence of information processing disturbances. 
On the other hand, the model assumes that B unusual perceptual 
experiences or thought contents identical to APS might occur dur-
ing childhood and early adolescence as an expression of not yet fully 
matured cognitive abilities (gray-shaded curve). If their maturation is 
impaired by risk factors or stressors (flashes) or neurodevelopmental 
disturbances in information processing (incl. BS), APS might persist 
or progress (dotted line), potentially leading to schizotypal traits and/
or psychosis
 European Archives of Psychiatry and Clinical Neuroscience
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Strengths and limitations
While our results open exciting perspectives for future early 
psychosis research, some limitations have to be kept in 
mind [8]. An obvious limitation refers to the large number 
of analyses we have performed, which may have increased 
the risk for a type 1 error. However, it was proposed that no 
accumulation of the assessment-related type I error occurs 
in multiple testing when assessments are completely depend-
ent of each other [43]. Thus, with the data on frequency and 
novelty requirements completely depending on the preva-
lence data (i.e., a BS can only be rated for novelty and fre-
quency of occurrence when it is reported to be present), an 
accumulation of the type I error by analyses of the criteria-
related requirements in addition to the prevalence data can 
be assumed to be low if not absent. The same consideration 
applies to the dependency of the cognitive and perceptive 
BS subgroup analyses on the total BS analyses, i.e., on the 
variable “at least one BS”. However, to reduce any remain-
ing type I error accumulation related to the multiple analyses 
of different outcomes, we applied bootstrapping to validate 
the accuracy of our results.
Moreover, our results call for replication in clinical 
samples (as provided already for attenuated and transient 
psychotic symptoms [9, 11]) as well as in even larger com-
munity samples with a similarly broad age range and suffi-
ciently large subsamples below the age of 16. These should 
be large enough to enable simultaneous study of the inter-
action between age and gender, since gender differences in 
brain maturation [44, 45] might lead to lower age thresh-
olds in the clinical significance of BS and possibly APS in 
females compared to males. Gender might also play a role in 
higher age, particularly with regard to the second onset peak 
of schizophrenia in women [46]; and possible gender-related 
age effects on the prevalence and clinical significance of BS 
in samples older than age 40 still warrant examination.
Furthermore, more detailed assessment of the age-at-
onset and course of BS in future studies will support an 
estimation of the relative contribution of neurodevelopmen-
tal processes with an onset of BS below the respective age 
threshold and of neurodegenerative processes with an onset 
of BS above the respective age threshold on the occurrence 
of BS beyond their progression into frank psychosis. Their 
longitudinal examination will clarify their relation to frank 
psychosis, other mental disorders, subclinical states with 
mental problems, mental health and mental well-being; in 
addition, resilience and protective factors should be assessed 
for their assumed high impact on the development of symp-
toms thought to be based on BS, such as attenuated and 
frank psychotic symptoms [47].
Future studies on developmental effects should also 
address the role of BS that are part of the Adynamia section 
of the SPI-CY (e.g., disturbances in drive and affect and 
unspecific cognitive BS) and that were suggested to play an 
important role in the early detection of psychosis in children 
and adolescents, but not adults [14, 15].
Lastly, differences in assessment might be considered 
to have affected the results. However, we have found that 
both face-to-face and telephone-interviews enabled a reli-
able assessment of APS and BS across age groups [20] and 
that BS age thresholds did not follow the age threshold of 
assessment modes. Rather, the use of psychosis-risk crite-
ria identical to those adopted in clinical settings and the 
assessment of symptoms by an established interview for BS, 
conducted by trained and closely supervised clinical psy-
chologists, are strengths of this study and ensure the high 
quality of the data.
Outlook
In concert with earlier findings of an age effect on APS 
[7–10], our findings emphasize the urgent need to address 
the differential effects of perceptive and non-perceptive (i.e., 
cognitive) psychosis-risk phenomena and their interaction 
with age in terms of neuro-psychological and neurobiologi-
cal development in future studies, particularly longitudinal 
studies of conversion to psychosis [16, 48]. Further, they 
indicate a need for differential examination of developmen-
tal factors affecting prevalence and clinical significance of 
APS and BS. Such symptomatically sophisticated future 
studies hold the potential to shed new light on the develop-
ment of psychosis and the various neuro-psychological and 
neurobiological processes involved in this, likely to different 
degrees [49]. Because different processes might signal dif-
ferent treatment needs, such an in-depth understanding of 
the development of different symptoms will also serve the 
development of more efficient personalized interventions.
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